Super toughquestion!
Having extracted the BRCA1 and BRCA2 genes from human DNA to isolate them as a research subject, Myriad Genetics feels it is entitled to its patent on the new DNA compound , but petitioners in a Supreme Court case are contestingit on the grounds that a company cannot copyright nature.
A. Having extracted the BRCA1 and BRCA2 genes from human DNA to isolate them as a research subject, Myriad Genetics feels it is entitled to its patent on the new DNA compound
Correct.
...
Having extracted the BRCA1 and BRCA2 genes from human DNA to isolate them as a research subject, Myriad Genetics feels it is entitled to its patent on the new DNA compound , but petitioners in a Supreme Court case are contestingit on the grounds that a company cannot copyright nature.
A. Having extracted the BRCA1 and BRCA2 genes from human DNA to isolate them as a research subject, Myriad Genetics feels it is entitled to its patent on the new DNA compound
Correct.
...
.jpg)
